Added to YB: 2021-05-06
Pitch date: 2021-05-06
ETNB:US [bullish]
89bio, Inc.
-39.49%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.
Market Cap
$2.3B
Pitch Price
$24.52
Price Target
N/A
Dividend
N/A
EV/EBITDA
-3.84
P/E
-4.35
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
89bio Inc ETNB:US
A summary for this pitch has not been created yet.
Read full article (0 min)